8 not yet recruiting, 3 recruiting. 7 Phase 2, 5 Phase 3, 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Not yet recruiting 7 |
| Phase 3 | 5 | Not yet recruiting 5 |
| Phase 1 | 3 | Not yet recruiting 3 |
| Not applicable | 2 | Recruiting 2 |
Follow Zhongming Qiu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders Ripertamab - Neuromyelitis Optica Spectrum Disease (NMOSD), Ripertamab | Phase 1 / Phase 2 | Not yet recruiting | Zhongming Qiu | 20 | 2026-09-30 | 2026-09-21 |
| An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Obinutuzumab β - Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Obinutuzumab β | Phase 1 / Phase 2 | Not yet recruiting | Zhongming Qiu | 24 | 2026-07-15 | 2026-07-10 |
| TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM) Telitacicept 240mg - Inflammatory Myopathy | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 30 | 2026-02-02 | 2026-01-21 |
| Ripertamab for the Treatment of Myasthenia Gravis ripertamab - Myasthenia Gravis (MG) | Phase 1 / Phase 2 | Not yet recruiting | Zhongming Qiu | 20 | 2026-02-01 | 2026-01-28 |
| Efgartigimod for the Treatment of Guillain-Barré Syndrome efgartigimod - Guillain-Barre Syndrome (GBS) | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 20 | 2025-04-13 | 2025-03-20 |
| Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy ripertamab, Placebo - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase 3 | Not yet recruiting | Zhongming Qiu | 175 | 2025-03-15 | 2025-03-05 |
| Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) Blinatumomab - Myasthaenia Gravis | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 10 | 2024-11-30 | 2024-11-12 |
| Tirofiban for Successful Endovascular Stroke Thrombectomy Intraarterial and intravenous tirofiban, Intraarterial and intravenous placebo - Stroke, Acute Ischemic | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 712 | 2024-07-31 | 2024-05-16 |
| Endovascular Treatment for eXtra-Large Ischemic Stroke Medical management, Endovascular thrombectomy - Stroke, Acute Ischemic | Not applicable | Recruiting | Zhongming Qiu | 286 | 2024-06-16 | 2025-12-26 |
| Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke medical management, endovascular thrombectomy - Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion | Recruiting | Zhongming Qiu | 1000 | 2024-01-20 | 2025-12-31 | |
| DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage Minimally Invasive Hematoma Evacuation, Best Medical Therapy - Stroke Hemorrhagic | Not applicable | Recruiting | Zhongming Qiu | 100 | 2023-08-03 | 2023-09-13 |
Ischemic Stroke (3) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (2) · Cerebral Hemorrhage (1) · Guillain-Barre Syndrome (1) · Hemorrhagic Stroke (1) · Myasthenia Gravis (1) · Myositis (1)
Practice Management, Medical (2) · Infusions, Intra-Arterial (1) · Tirofiban (1) · blinatumomab (1) · efgartigimod alfa (1) · telitacicept (1)
China (3)
Guangxiong Yuan (2) · Chenghua Xu (1) · Chong Zheng (1) · Congguo Yin (1) · Tingyu Yi (1) · Zhongfan Ruan (1)